dataService

您的位置: 首页 > 数据服务 > 数据列表页

筛选

共检索到16条 ,权限内显示50条;

Data from: Drug approval status and recommendations for listing on public formularies: a Canadian cohort analysis
负责人:
关键词:
Health policy;Health economics;2003-2017;Organisation of health services
DOI:
doi:10.5061/dryad.tv138
摘要:
Objectives Investigate if the recommendations by the Common Drug Review (CDR) and the pan-Canadian Oncology Drug Review (pCODR) to provinc
Data from: Financial conflicts of interest of clinicians making submissions to the panCanadian Oncology Drug Review: a descriptive study
负责人:
关键词:
clinician;financial conflict-of-interest;Medicines;panCanadian Oncology Drug Review;funding recommendations
DOI:
doi:10.5061/dryad.qs41mg4
摘要:
Objectives: This study examines financial conflict-of-interest (FCOI) of clinicians who made submissions to the panCanadian Oncology Drug Review
Data from: Oncological and surgical outcome after treatment of pelvic sarcomas
负责人:
关键词:
Tumor resection;Sarcomas;Plastic surgery and reconstructive techniques;Cancer treatment;Surgical resection;Surgical oncology;Surgical and invasive medical procedures;Soft tissues
DOI:
doi:10.5061/dryad.vn757
摘要:
Background and Objectives. Treatment of pelvic tumors remains challenging due to complex anatomy, poor oncological outcome and high complication
Data from: Development and application of a novel metric to assess effectiveness of biomedical data
负责人:
关键词:
oncology;Epidemiology;Health informatics
DOI:
doi:10.5061/dryad.54r13
摘要:
Objective: Design a metric to assess the comparative effectiveness of biomedical data elements within a study that incorporates their statistical
Data from: Outcome of breast cancer in Moroccan young women correlated to clinic-pathological features, risk factors and treatment
负责人:
关键词:
young women;risk factors;event-free survival;molecular subtypes.;Breast Cancer
DOI:
doi:10.5061/dryad.2pc43
摘要:
included 716 cases of breast cancer women diagnosed in 2009 at the National Institute of Oncology of Rabat. Patients were divided into two groups accordin
Human Lim Domain Kinase 1 (Limk1), Kinase Domain; A Target Enabling Package
负责人:
关键词:
oncology protein target enabling package disease structure cancer neuropsychiatry neuro neurological genetic disorders metabolic diseases
DOI:
doi:10.5281/zenodo.1287260
摘要:
e we present a target enabling package for the therapeutic target LIMK1. We include crystal structures of BMPR2, LIMK1, LIMK2 and the LIMK1-cofilin complex
Human Lim Domain Kinase 1 (Limk1), Kinase Domain; A Target Enabling Package
负责人:
关键词:
oncology protein target enabling package disease structure cancer neuropsychiatry neuro neurological genetic disorders metabolic diseases
DOI:
doi:10.5281/zenodo.1241027
摘要:
e we present a target enabling package for the therapeutic target LIMK1. We include crystal structures of BMPR2, LIMK1, LIMK2 and the LIMK1-cofilin complex
Human LIM domain kinase 1 (LIMK1), kinase domain; A Target Enabling Package
负责人:
关键词:
oncology protein target enabling package disease structure cancer neuropsychiatry neuro neurological genetic disorders metabolic diseases
DOI:
doi:10.5281/zenodo.1219706
摘要:
e we present a target enabling package for the therapeutic target LIMK1. We include crystal structures of BMPR2, LIMK1, LIMK2 and the LIMK1-cofilin complex
Data from: Quantifying patient preferences for symptomatic breast clinic referral: a decision analysis study
负责人:
关键词:
oncology;Quality in health care;Epidemiology
DOI:
doi:10.5061/dryad.k15f3t5
摘要:
Objectives: Decision analysis study that incorporates patient preferences and probability estimates to investigate the impact of women’s preferenc
Data from: Ellipsoid segmentation model for analyzing light-attenuated 3D confocal image stacks of fluorescent multi-cellular spheroids
负责人:
关键词:
fluorescence;3D images analysis;segmentation;3D cell culture;signal attenuation;multi-cellular spheroids
DOI:
doi:10.5061/dryad.0m9n7
摘要:
In oncology, two-dimensional in-vitro culture models are the standard test beds for the discovery and development of canc

首页上一页12下一页尾页

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充